These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10566797)

  • 21. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [With new strategies against vaccination gaps in adulthood].
    MMW Fortschr Med; 2007 Aug; 149(31-32):17. PubMed ID: 17849780
    [No Abstract]   [Full Text] [Related]  

  • 24. Simplified activity evaluation of several tetanus vaccines.
    Huet M; Relyveld E; Camps S
    Biologicals; 1992 Mar; 20(1):35-43. PubMed ID: 1610557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation and standardization of tests of tetanus toxoid potency. II. Elaboration of basic parameters of the tests on mice].
    Sawicki J
    Med Dosw Mikrobiol; 1985; 37(3-4):172-8. PubMed ID: 3831629
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation and standardization of tests of tetanus toxoid potency. I. Evaluation of Polish standards and serial production vaccines].
    Sawicki J
    Med Dosw Mikrobiol; 1985; 37(3-4):165-71. PubMed ID: 3831628
    [No Abstract]   [Full Text] [Related]  

  • 27. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraindications to vaccination in the Russian Federation.
    Tatochenko V; Mitjushin IL
    J Infect Dis; 2000 Feb; 181 Suppl 1():S228-31. PubMed ID: 10657219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):374-5. PubMed ID: 19373199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of the national reference standard for tetanus toxoid in Thailand.
    Pittayakhajonwut D; Ekthaicharern P; Hommalai G; Lohavech D; Jongkol R; Poredi I; Harjee N; Amen A; Suppasansathorn A; Phumiamorn S
    Biologicals; 2020 Mar; 64():73-75. PubMed ID: 31982246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity issues in the quality control of the new acellular pertussis vaccines.
    Mastrantonio P; Cerquetti M; Cardines R; Lande R; Ausiello CM; Cassone A
    Biologicals; 1999 Jun; 27(2):119-21. PubMed ID: 10600199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part I. Potency of DTP vaccine].
    Gzyl A; Gniadek G; Augustynowicz E; Rabczenko D; Husejnow B; Zawadka M; Slusarczyk J
    Przegl Epidemiol; 2004; 58(4):629-39. PubMed ID: 15810504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical analysis of the state of DTP vaccine production in Latin America and the Caribbean.
    Homma A; Di Fabio J; Miranda DP; Oliva OF
    Bull Pan Am Health Organ; 1994 Sep; 28(3):256-74. PubMed ID: 7951369
    [No Abstract]   [Full Text] [Related]  

  • 36. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test.
    Preneta-Blanc R; Rigsby P; Wilhelmsen ES; Tierney R; Brierley M; Sesardic D
    Biologicals; 2008 Sep; 36(5):315-26. PubMed ID: 18676158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part II. Consistency of control and production].
    Gzyl A; Gniadek G; Augustynowicz E; Rabczenko D; Husejnow B; Zawadka M; Slusarczyk J
    Przegl Epidemiol; 2004; 58(4):641-8. PubMed ID: 15810505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.